Last Updated: November 13, 2026

ASPIRIN; BUTALBITAL; CAFFEINE - Generic Drug Details

« Back to Dashboard


What are the generic sources for aspirin; butalbital; caffeine and what is the scope of freedom to operate?

Aspirin; butalbital; caffeine is the generic ingredient in five branded drugs marketed by Lgm Pharma, Mpp Pharma, Watson Labs, Allergan, Sandoz, Actavis Elizabeth, Fosun Pharma, Halsey, Hikma, Ivax Pharms, Puracap Pharm, Quantum Pharmics, Strides Pharma, Lannett, Dr Reddys Labs Sa, Novitium Pharma, and Stevens J, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

Five suppliers are listed for this compound.

Summary for ASPIRIN; BUTALBITAL; CAFFEINE
US Patents:0
Tradenames:5
Applicants:17
NDAs:21
Finished Product Suppliers / Packagers: 5
DailyMed Link:ASPIRIN; BUTALBITAL; CAFFEINE at DailyMed

US Patents and Regulatory Information for ASPIRIN; BUTALBITAL; CAFFEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE aspirin; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 074359-001 Aug 31, 1995 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Puracap Pharm BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine TABLET;ORAL 087048-002 Dec 9, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Quantum Pharmics BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine TABLET;ORAL 088972-001 Jun 18, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ivax Pharms BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine TABLET;ORAL 085441-002 Oct 31, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine TABLET;ORAL 086162-002 Feb 16, 1984 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lgm Pharma BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine CAPSULE;ORAL 205230-001 Oct 18, 2021 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.